Guided Therapeutics (OTCMKTS:GTHP) Shares Down 6.7% – Here’s Why

Guided Therapeutics Inc. (OTCMKTS:GTHP)’s stock price was down 6.7% during mid-day trading on Tuesday . The stock traded as low as $0.1989 and last traded at $0.23. Approximately 27,565 shares changed hands during mid-day trading, an increase of 87% from the average daily volume of 14,717 shares. The stock had previously closed at $0.2464.

Guided Therapeutics Trading Up 4.3%

The stock has a 50-day simple moving average of $0.33 and a two-hundred day simple moving average of $0.31. The firm has a market capitalization of $22.20 million, a P/E ratio of -6.00 and a beta of 0.75.

Guided Therapeutics (OTCMKTS:GTHP) last issued its earnings results on Monday, March 30th. The company reported ($0.01) earnings per share for the quarter. The business had revenue of $0.59 million during the quarter.

About Guided Therapeutics

Guided Therapeutics, Inc is a medical device company focused on the development and commercialization of non?invasive optical diagnostic platforms for women’s health. Its flagship product, the LuViva® Advanced Cervical Scan, combines hyperspectral and reflectance imaging to support the early detection of cervical epithelial abnormalities. By capturing tissue fluorescence and reflectance signatures in real time, LuViva is designed to augment traditional visual inspection methods and assist clinicians during colposcopic evaluations.

The company secured 510(k) clearance from the U.S.